Role of 1,4-Benzothiazine derivatives in medicinal chemistry

Mini-Reviews in Medicinal Chemistry

Volumn 5, Issue 12, 2005, Pages 1061-1073

  Fringuelli, R ^a   Milanese, L ^a   Schiaffella, F ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

7 [1 [(4CHLOROBENZYL)OXYL] 2 (1H 1 IMIDAZOLYL)ETHYL] 4 METHYL 3,4 DIHYDRO 2H 1,4 BENZOTHIAZIN 3 ONE; 7 [3 [4 (2 QUINOLINYLMETHYL) 1 PIPERAZINYL]PROPOXY] 2,3 DIHYDRO 4H 1,4 BENZOTHIAZIN 3 ONE; ADENOSINE A2 RECEPTOR; ADENOSINE A3 RECEPTOR; ALDOSE REDUCTASE INHIBITOR; ALPHA ADRENERGIC RECEPTOR; ANTIALLERGIC AGENT; ANTIFUNGAL AGENT; ANTINEOPLASTIC AGENT; ANTIRHEUMATIC AGENT; BENZOTHIAZINE DERIVATIVE; BETA ADRENERGIC RECEPTOR; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL L TYPE; CROMAKALIM; DEXAMETHASONE; DIHYDROFOLATE REDUCTASE; DILTIAZEM; METHOTREXATE; N [[4 [(2,4 DIAMINO 6 PTERIDINYL)METHYL] 3,4 DIHYDRO 2H 1,4 BENZOTHIAZIN 7 YL]CARBONYL]HOMOGLUTAMIC ACID; NAFTOPIDIL; NICORANDIL; NIFEDIPINE; PINACIDIL; POTASSIUM CHANNEL STIMULATING AGENT; SESAMODIL FUMARATE; SPR 210; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UNINDEXED DRUG; VERAPAMIL; VUFK 8788; ZOPOLRESTAT;

ANTIARRHYTHMIC ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIHYPERTENSIVE ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; BINDING AFFINITY; CANDIDIASIS; DOSE RESPONSE; DRUG BINDING; DRUG EFFICACY; DRUG RESEARCH; DRUG SYNTHESIS; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; IMMUNOSTIMULATION; IN VITRO STUDY; IN VIVO STUDY; LOW DRUG DOSE; NEUROPROTECTION; NONHUMAN; RHEUMATOID ARTHRITIS; STATISTICAL SIGNIFICANCE; STRUCTURE ACTIVITY RELATION;

EID: 28444469299     PISSN: 13895575     EISSN: None     Source Type: Journal    
DOI: 10.2174/138955705774933365     Document Type: Article

References (80)

1. Gupta, R.R. Phenothiazines and Benzothiazines Chemical and Biomedical Aspects, Elsevier: Amsterdam, 1988.
2. Imwidthaya, P.; Poungvarin, N. Postgrad. Med. J., 2000, 76, 85.
3. Steenbergen, J.N.; Casadevall, A. J. Clin. Microbiol., 2000, 38, 1974.
4. Maertens, J.A.; Boogaerts M.A. Curr. Pharm. Des., 2000, 6, 225.
5. Sheehan, D.J.; Hitchcock, C.A.; Sibley, C.M. Clin. Microbiol. Rev., 1999, 12, 40.
6. Lamb, D.; Kelly, D.; Kelly, S. Drug Res. Updates, 1999, 2, 390.
7. Baruffini, A.; Pagani, G.; Amoretti, L. Il Farmaco, 1967, 22, 528.
8. Fringuelli, R.; Schiaffella, F.; Bistoni, F.; Pitzurra, L.; Vecchiarelli, A. Bioorg. Med. Chem., 1998, 6, 103.
9. Schiaffella, F.; Guarraci, A.; Fringuelli, R.; Pitzurra, L.; Bistoni, F.; Vecchiarelli, A. Med. Chem. Res., 1999, 9, 291.
10. Fringuelli, R.; Schiaffella, F.; Vecchiarelli, A. J. Chemother., 2001, 13, 9.
11. Pitzurra, L.; Fringuelli, R.; Perito, S.; Schiaffella, F.; Barluzzi, R.; Bistoni, F.; Vecchiarelli, A. Antimicrob. Agents Chemother., 1999, 43, 2170.
12. Podust, L. M.; Poulos, T. L.; Waterman, M.R. PNAS, 2001, 98, 3068.
13. Macchiarulo, A.; Costantino, G.; Fringuelli, D.; Vecchiarelli, A.; Schiaffella, F.; Fringuelli, R. Bioorg. Med. Chem., 2002, 10, 3415.
14. Gubner, R.; August, S.; Ginsberg, V. Am. J. Med. Sci., 1951, 221, 176.
15. Chabner, B.A.; Allegra, C.J.; Curt, G.A.; Clendeninn, N.J.; Baram, J.; Koizumi, S.; Drake, J.C.; Jolivet, J. J. Clin. Invest., 1985, 76, 907.
16. Ahern, M.J.; Kevat, S.; Hill, W.; Hayball, P.J.; Harley, H.; Hall, P. Ann. Rheum. Dis., 1991, 50, 477.
17. Matsuoka, H.; Ohi, N.; Mihara, M.; Suzuki, H.; Miyamoto, K.; Maruyama, N.; Tsuji, K.; Kato, N.; Akimoto, T.; Takeda, Y.; Yano, K.; Kuroki, T. J. Med. Chem., 1997, 40, 105.
18. Urakawa, K.; Mihara, M.; Takagi, N.; Kawamura, A.; Akamatsu, K.; Takeda, Y. Eur. J. Pharmacol., 2002, 435, 237.
19. Urakawa, K.; Mihara, M.; Suzuki, T.; Kawamura, A. Immunopharmacology, 2000, 48, 137.
20. Montesinos, M.C.; Desai, A.; Delano, D.; Chen, J.F.; Fink, J.S.; Jacobson, M.A.; Cronstein, B.N. Arthritis Rheum., 2003, 48, 240.
21. Mihara, M.; Takagi, N.; Urokawa, K.; Morya, Y.; Takeda, Y. Int. J. Immunopharmacol., 1997, 19, 67.
22. Timmerman, H.; Onogi, K.; Tamura, M.; Tohma, T.; Wada, Y. PCT Int. Appl. 1999, WO 9902520
23. Toshiaki, T.; Matsumoto, J.; Tohma, T.; Kanke, T.; Wada, Y.; Nagao, M.; Inagaki, N.; Nagai, H.; Zhang, M.; Timmerman, H. Jpn. J. Pharmacol., 2001, 86, 55.
24. Toshiaki, T.; Watanabe, C.; Saiki, I.; Tohma, T.; Nagai, H. Biol. Pharm. Bull., 2001, 24, 1127.
25. Kador, P.F.; Kinoshita, J.H.; Sharpless, E. J. Med. Chem., 1985, 28, 841.
26. Tawada, H.; Sugiyama, Y.; Ikeda, H.; Yamamoto, Y.; Meguro, K. Chem. Pharm. Bull., 1990, 38, 1238.
27. Aotsuka, T.; Hosono. H.; Kurihara, T.; Nakamura, Y.; Matsui, T.; Kobayashi, F. Chem. Pharm. Bull., 1994, 42, 1264.
28. Bouzoubaa, M.; Leclerc, G.; Decker, N.; Andermann, G. J. Med. Chem., 1984, 27, 1291.
29. Imbs, J.L.; Miesch, F.; Schwartz, J.; Velley, J.; Leclerc, G.; Mann, A.; Wermuth, C. G. Br. J. Pharmacol., 1977, 60, 357.
30. Prasad, N.R. J. Med. Chem., 1969, 12, 290.
31. Cecchetti, V.; Fringuelli, R.; Schiaffella, F.; Fravolini, A.; Bruni, G.; Fiaschi, A. I.; Segre, G. Eur. J. Med. Chem., 1989, 24, 479.
32. Schiaffella, F.; Fringuelli, R.; Cecchetti, V.; Fravolini, A.; Angeli, P.; Marucci, G. Il Farmaco, 1990, 45, 1299.
33. Gifford, R.W.; Borazanian, R.A. Hypertension, 1989, 13, 119.
34. Cecchetti, V.; Schiaffella, F.; Tabarrini, O.; Zhou, W.; Fravolini, A.; Goi, A.; Bruni, G.; Segre, G. Eur. J. Med. Chem., 1991, 26, 381.
35. Cecchetti, V.; Fravolini, A.; Schiaffella, F.; Tabarrini, O.; Bruni, G.; Segre, G. J. Med. Chem., 1993, 36, 157.
36. Cecchetti, V.; Schiaffella, F.; Tabarrini, O.; Fravolini, A. Bioorg. Med. Chem. Lett., 2000, 10, 465.
37. De Marinis, R.M.; Wise, M.; Hieble, J.P.; Ruffolo, Jr. R.R. In The α-1 Adrenergic Receptors; Ruffolo, Jr. R. R., Ed.; Humana Press: Clifton, NJ, 1987; pp. 241-258.
38. Russo, F.; Romeo, G.; Guccione, S.; De Blasi, A. J. Med. Chem., 1991, 34, 1850.
39. Chern, J.W.; Tao, P.L.; Wang, K.C.; Gutcait, A.; Liu, S.W.; Yen, M.H.; Chien, S.L.; Rong, J.K. J. Med. Chem., 1998, 41, 3128.
40. Cecchetti, V.; Fravolini, A.; Fringuelli, R.; Schiaffella, F.; Mascellani, G.; Pagella, P.G.; Rugarli, P.L. Il Farmaco, 1987, 42, 61.
41. Quadri, L.; Gobblini, M.; Monti, L. Curr. Pharm. Des., 1998, 4, 489.
42. Gopalakrishnan, M.; Janis, R.A.; Triggle, D.J. Drug Dev. Res., 1993, 28, 95.
43. Ulrich, Q. Trends Pharmacol. Sci., 1993, 14, 332.
44. Matsumoto, Y.; Tsuzuki, R.; Matsuhisa, A.; Yoden, T.; Yamagiwa, Y.; Yanagisawa, I.; Shibanuma, T.; Nohira, H. Bioorg. Med. Chem., 2000, 8, 393.
45. Cecchetti, V.; Calderone, V.; Tabarrini, O.; Sabatini, S.; Filipponi, E.; Testai, L.; Spogli, R.; Martinotti, E.; Fravolini, A. J. Med. Chem., 2003, 46, 3670.
46. Varadi, G.; Mori, Y.; Mikala, G.; Schwartz, A. Trends Pharmacol. Sci., 1995, 16, 43.
47. Singh, B.N.; Ellrodt, G.; Peter, C.T. Drugs, 1978, 15, 169.
48. Opie, L.H. Lancet, 1980, I, 806.
49. Klieman, R.L.; Stephenson, S.H. Q. Rev. Drug Metab. Drug Interact., 1985, 5, 193.
50. Gibson, R.S.; Boden, W.E.; Theroux, P.; Strauss, H.D.; Pratt, C.M.; Gheorghiade, M.; Capone, R.J.; Crawford, M.H.; Schlant, R.C.; Kleiger, R.E.; Young, P.M.; Schechtman, K.; Perryman, M.B.; Roberts, R. N. Engl. J. Med., 1986, 315, 423.
51. Fujita, M.; Ito, S.; Ota, A.; Kato, N.; Yamamoto, K.; Kawashima, Y.; Yamauchi, H.; Iwao, J. J. Med. Chem., 1990, 33, 1898.
52. Kojic-Prodic, B.; Ruzic-Toros, Z.; Sunjic, V.; Decorte, E.; Moimas, F. Helv. Chim. Acta, 1984, 67, 916.
53. Ota, A.; Kawashima, Y.; Ohishi, H.; Ishida, T. Chem. Pharm. Bull., 1993, 41, 1681.
54. Kritz, H.; Underwood, S.R.; Sinzinger, H. Wr. Klin. Wschr., 1996, 108, 98.
55. Kritz, H.; Underwood, S.R.; Sinzinger, H. Wr. Klin. Wschr., 1996, 108, 123.
56. Bouvier, C.A. Drug Res., 1983, 33, 1401.
57. Holzgreve, H.; Burkle, B. J. Hypertens., 1993, 11, 55.
58. Weinstein, D.B.; Heider, J.G. Am. J. Cardiol., 1987, 59, B163.
59. Wolfram, R.M.; Kritz, H.; Oguogho, A.; Sinzinger, H. Thromb. Res., 2002, 106, 187.
60. Miyawaki, N.; Yamazaki, T.; Furuta, T.; Shigei, T.; Yamauchi, H. Drug Dev. Res., 1991, 22, 293.
61. Kodama, I.; Suzuki, R.; Maruyama, K.; Toyama, J. Br. J. Pharmacol., 1995, 114, 503.
62. Yoshikawa, H.; Shimizu, E.; Kawahara, K.; Kuniyasu, A.; Shibano, T.; Nakayama, H. Heterocycles, 2003, 59, 613.
63. Hara, Y.; Nakaya, H. Br. J. Pharmacol., 1995, 116, 2750.
64. Tanaka, T. Jpn. J. Pharmacol., 1988, 46, 101.
65. Levin, R.M.; Weiss, B. Mol. Pharmacol., 1977, 13, 690.
66. Ingagki, M.; Tanaka, T.; Hidaka, H. Pharmacoogy, 1983, 27, 125.
67. Kajino, M.; Mizuno, K.; Tawada, H.; Shibouta, Y.; Nishikawa, K.; Meguro, K. Chem. Pharm. Bull., 1991, 39, 2888.
68. Steen, P.A.; Newberg, L.A.; Milde, J.H.; Michenfelder, J.D. J. Cereb. Blood Flow Metab., 1983, 3, 38.
69. Alps, B.J.; Calder, C.; Hass, W.K.; Wilson, A.D. Br. J. Pharmacol., 1987, 91, 312P.
70. Maeda, K.; Ozeki, M.; Yasuda, K.; Kodato, S.; Kudo, Y. Eur. Pat. Appl. EP0441539, 1991.
71. Ishii, T.; Okamoto, M.; Kume, T.; Narita, H.; Kudo, Y.; Matsuoka, Y. Jpn. J. Pharmacol., 1996, 71, 175P.
72. Kobayashi, T.; Strobeck, M.; Schwartz, A.; Mori, Y. Eur. J. Pharmacol., 1997, 332, 313.
73. Okuyama, K.; Kiuchi, S.; Okamoto, M.; Narita, H.; Kudo, Y. Jpn. J. Pharmacol., 1999, 81, 170.
74. White, O.B.; Norris, J.W.; Hachinski, V.C.; Lewis, A. Stroke, 1979, 10, 743.
75. Okuyama, K.; Kiuchi, S.; Okamoto, M.; Narita, H.; Kudo, Y. Eur. J. Pharmacol., 2000, 398, 209.
76. Shen, X. M.; Dryhurst, G. Chem. Res. Toxicol., 1996, 9, 751.
77. Li, H.; Dryhurst, G. J. Neurochem., 1997, 69, 1530.
78. Inoue, S.; Hasegawa, K.; Wakamatsu, K.; Ito, S. Melanoma Res., 1998, 8, 105.
79. Marchetti, C.; Ulisse, S.; Bruscoli, S.; Migliorati, G.; Schiaffella, F.; Cifone, G.; Riccardi, C.; Fringuelli, R. J. Pharmacol. Exp. Ther., 2002, 300, 1.
80. Fringuelli, R.; Schiaffella, F.; Utrilla Navarro, M.P.; Milanese, L.; Santini, C.; Rapucci, M.; Marchetti, C.; Riccardi, C. Bioorg. Med. Chem., 2003, 11, 3245.